NCT02560077

Brief Summary

Cashew or Anacardium occidentale L. is a plant in a family of Anacardiaceae. The fruit of cashew or cashew apple may be consumed fresh, but contains high quantities of tannins yielding a bitter taste and dry mouth feel. Therefore, it is more often prepared as beverage. It is rich in carbohydrate and vitamin C. It is also claimed for numerous ailments including antitumor, antimicrobial, urease inhibitory and lipoxygenase activity. In addition, cashew apple juice also has excellent anti-oxidant potential. The preclinical data also demonstrated that cognitive deficit rats induced by cholinotoxin which received A.occidentale or cashew fruit juice for 2 weeks showed the neuroprotective and cognitive enhancing effects.Therefore, the potential benefit of Cashew apple juice on physical fitness and psychological fitness of the middle aged and elderly is focused.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for phase_1 healthy

Timeline
Completed

Started Dec 2010

Longer than P75 for phase_1 healthy

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2015

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 25, 2015

Completed
Last Updated

March 23, 2016

Status Verified

March 1, 2016

Enrollment Period

3 years

First QC Date

April 11, 2015

Last Update Submit

March 21, 2016

Conditions

Keywords

cognitivememoryphysical fitnesspsychological fitnesselderlymiddle aged

Outcome Measures

Primary Outcomes (1)

  • Cognitive processing (P300) and attention (N100) using Event Related Potential

    4 months

Secondary Outcomes (11)

  • Accuracy and speed of working memory using computerized battery test

    4 months

  • Mood evaluation using Bond-laddeer questionnaire

    4 months

  • Psychological symptom using SCL-90 questionnaire

    4 months

  • Malondialdehyde level (MDA) in the serum

    4 months

  • Acetylcholinesterase and monoamine oxidase-B activities in serum

    4 months

  • +6 more secondary outcomes

Study Arms (3)

placebo

PLACEBO COMPARATOR

The placebo and cashew apple fruit juice had the same color and smell

Other: placebo

cashew apple juice 120 mg/day

ACTIVE COMPARATOR

The subjects who were assigned as the low dose treatment group received cashew apple fruit juice extract at dose of 120 mg/day

Other: cashew apple juice

cashew apple juice 240 mg/day

ACTIVE COMPARATOR

The subjects who were assigned as the high dose treatment group received cashew apple fruit juice extract at dose of 240 mg/day

Other: cashew apple juice

Interventions

placeboOTHER

Subject receive the Placebo product (placebo group had same color and smell of treatment groups)

placebo

Subject received the cashew apple juice at dose of 120 mg/day after meal

cashew apple juice 120 mg/day

Eligibility Criteria

Age55 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Live in Khon Kaen, Thailand
  • Aged between 55-70 years old
  • Body mass index is 18.5 to 24.9
  • Signed a written consent form
  • In order to ensure the healthy condition , all subjects were subjected to history interviewed by the semi structure form. Moreover they all were assessed physical exam by physician
  • All volunteers should not use other nutraceutical compounds or herbs or drugs which influenced on the nervous system function at least 1 month before participating in this study
  • On the day of the study, all volunteers felt well and refrain from drinking tea or coffee, or smoking more than 10 pieces/ day

You may not qualify if:

  • Cardiovascular disease
  • Respiratory disease
  • Neuropsychological disorders
  • Diabetes
  • Liver disease
  • Renal disease
  • Endocrine dysfunction
  • Autoimmune disease
  • Hematological disorder
  • Cancer
  • Brain inflammation, head injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Jintanaporn Wattanathorn

    Integrated complementary alternative medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Integrative complementary alternative medicine

Study Record Dates

First Submitted

April 11, 2015

First Posted

September 25, 2015

Study Start

December 1, 2010

Primary Completion

December 1, 2013

Study Completion

December 1, 2014

Last Updated

March 23, 2016

Record last verified: 2016-03